| Dr Morium Akthar, MD | |
|
150 Bergen St, University Hospital, Newark, NJ 07103-2496 | |
| (973) 972-6056 | |
| Not Available |
| Full Name | Dr Morium Akthar |
|---|---|
| Gender | Female |
| Speciality | Critical Care (intensivists) |
| Experience | 14 Years |
| Location | 150 Bergen St, Newark, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184941197 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 25MA09305800 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hackensackumc Mountainside | Montclair, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mpv New Jersey Md Services Pc | 5991097669 | 120 |
News Archive
A federal appeals court on Tuesday said it will not revisit its decision to uphold settlements that allow pharmaceutical companies to pay competitors to keep generic versions of their drugs off the market, The Wall Street Journal reports. "In April, the U.S. Second Circuit Court of Appeals [in New York] affirmed the legality of a settlement in which Bayer AG, in essence, paid Barr Pharmaceuticals Inc., a potential generic competitor, to drop its patent challenge to Cipro, a Bayer antibiotic."
Australian females will be one jump ahead of some of their counterparts elsewhere in the world with the first vaccinations against cervical cancer taking place in Brisbane today.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that the non-small-cell lung cancer (NSCLC) drug market will increase from approximately $4 billion in 2009 to more than $6.5 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.
Innovista Health Solutions, a leading Population Health Management organization enabling providers to successfully participate in value based agreements, has partnered with the newly established Houston Regional Accountable Care Organization, LLC.
› Verified 5 days ago
| Entity Name | University Physician Associates Of New Jersey Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760492367 PECOS PAC ID: 9830003417 Enrollment ID: O20031118000289 |
News Archive
A federal appeals court on Tuesday said it will not revisit its decision to uphold settlements that allow pharmaceutical companies to pay competitors to keep generic versions of their drugs off the market, The Wall Street Journal reports. "In April, the U.S. Second Circuit Court of Appeals [in New York] affirmed the legality of a settlement in which Bayer AG, in essence, paid Barr Pharmaceuticals Inc., a potential generic competitor, to drop its patent challenge to Cipro, a Bayer antibiotic."
Australian females will be one jump ahead of some of their counterparts elsewhere in the world with the first vaccinations against cervical cancer taking place in Brisbane today.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that the non-small-cell lung cancer (NSCLC) drug market will increase from approximately $4 billion in 2009 to more than $6.5 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.
Innovista Health Solutions, a leading Population Health Management organization enabling providers to successfully participate in value based agreements, has partnered with the newly established Houston Regional Accountable Care Organization, LLC.
› Verified 5 days ago
| Entity Name | Mpv New Jersey Md Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215391271 PECOS PAC ID: 5991097669 Enrollment ID: O20160718000760 |
News Archive
A federal appeals court on Tuesday said it will not revisit its decision to uphold settlements that allow pharmaceutical companies to pay competitors to keep generic versions of their drugs off the market, The Wall Street Journal reports. "In April, the U.S. Second Circuit Court of Appeals [in New York] affirmed the legality of a settlement in which Bayer AG, in essence, paid Barr Pharmaceuticals Inc., a potential generic competitor, to drop its patent challenge to Cipro, a Bayer antibiotic."
Australian females will be one jump ahead of some of their counterparts elsewhere in the world with the first vaccinations against cervical cancer taking place in Brisbane today.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that the non-small-cell lung cancer (NSCLC) drug market will increase from approximately $4 billion in 2009 to more than $6.5 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.
Innovista Health Solutions, a leading Population Health Management organization enabling providers to successfully participate in value based agreements, has partnered with the newly established Houston Regional Accountable Care Organization, LLC.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Morium Akthar, MD 150 Bergen St, Newark, NJ 07103-2496 Ph: (973) 972-6111 | Dr Morium Akthar, MD 150 Bergen St, University Hospital, Newark, NJ 07103-2496 Ph: (973) 972-6056 |
News Archive
A federal appeals court on Tuesday said it will not revisit its decision to uphold settlements that allow pharmaceutical companies to pay competitors to keep generic versions of their drugs off the market, The Wall Street Journal reports. "In April, the U.S. Second Circuit Court of Appeals [in New York] affirmed the legality of a settlement in which Bayer AG, in essence, paid Barr Pharmaceuticals Inc., a potential generic competitor, to drop its patent challenge to Cipro, a Bayer antibiotic."
Australian females will be one jump ahead of some of their counterparts elsewhere in the world with the first vaccinations against cervical cancer taking place in Brisbane today.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that the non-small-cell lung cancer (NSCLC) drug market will increase from approximately $4 billion in 2009 to more than $6.5 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan.
Innovista Health Solutions, a leading Population Health Management organization enabling providers to successfully participate in value based agreements, has partnered with the newly established Houston Regional Accountable Care Organization, LLC.
› Verified 5 days ago
Dr. Xiaoning Joanie Zhu, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 741 Broadway, Newark, NJ 07104 Phone: 973-481-1300 | |
Lissette Maria Cespedes, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 185 S Orange Ave, Msb I588, Newark, NJ 07103 Phone: 973-972-3479 | |
Dr. Pankaja Achar, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 194 Clinton Ave Fl 2, Newark, NJ 07108 Phone: 973-273-1515 Fax: 973-230-0883 | |
Marc H. Lavietes, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 90 Bergen St, Doc 4500, Newark, NJ 07103 Phone: 973-972-2500 Fax: 973-972-2510 | |
Dr. Hoi-wing Susanna Yim, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 111 Central Ave, Newark, NJ 07102 Phone: 973-877-5000 | |
Tharakeswari Selvakumar, MD, PHD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 150 Bergen St # Uhi-248, Newark, NJ 07103 Phone: 973-972-6056 | |
Dr. Epifania Lopez Ramirez, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1119 Broad St, Newark, NJ 07114 Phone: 973-824-8226 Fax: 973-824-0193 |